← Back
$KNSA All transactions

Kiniksa Pharmaceuticals International, plc

▼ SELL 10b5-1 Plan

$ Value

$573K

Shares

21,254

Price

$27

Filed

May 1

Insider

Name

Ragosa Mark

Title

CHIEF FINANCIAL OFFICER

CIK

0001835458

Roles

Officer

Transaction Details

Transaction Date

2025-04-30

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

27,009

Footnotes

This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 3, 2024. | This transaction was executed in multiple trades through a broker-dealer at prices ranging between $25.50 and $25.935. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. | The option is fully vested and exercisable. | The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2023.

Filing Info

Accession No.

0001415889-25-011690

Form Type

4

Issuer CIK

0001730430

Ragosa Mark's History

Date Ticker Type Value
2026-04-07 KNSA M
2026-04-07 KNSA F $64K
2026-04-07 KNSA M $0
2026-04-01 KNSA M
2026-04-01 KNSA F $121K
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0
2026-04-01 KNSA M $0
2026-04-01 KNSA M $0

Other Insiders at KNSA (90d)

Insider Bought Sold Last
Quart Barry D $345K 2026-04-06
Megna Michael R
CHIEF ACCOUNTING OFFICER
$309K 2026-04-09
Patel Sanj K
CHAIRMAN & CEO
$364K 2026-04-07
Paolini John F.
CHIEF MEDICAL OFFICER
2026-04-07
Ragosa Mark
CHIEF FINANCIAL OFFICER
2026-04-07
Moat Ross
CHIEF OPERATING OFFICER
$195K 2026-04-09
Tessari Eben
CHIEF STRATEGY OFFICER
2026-04-07